These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7118322)

  • 21. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
    Grimm L; Bircher J; Preisig R
    Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of triamterene and hydroxytriamterene sulfuric acid ester on diuresis and saluresis in rats after oral and intravenous application.
    Leilich G; Knauf H; Mutschler E; Völger KD
    Arzneimittelforschung; 1980; 30(6):949-53. PubMed ID: 7191270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism.
    Campillo B; Sherman E; Richardet JP; Bories PN
    Eur J Clin Nutr; 2001 Nov; 55(11):980-8. PubMed ID: 11641747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential depletion of carotenoids and tocopherol in liver disease.
    Leo MA; Rosman AS; Lieber CS
    Hepatology; 1993 Jun; 17(6):977-86. PubMed ID: 8514270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal.
    Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F
    Hepatology; 1999 Jun; 29(6):1818-24. PubMed ID: 10347125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of triamterene and its phase I and phase II metabolities on sodium transport of the isolated frog skin.
    Kramer HJ; Rörig M; Völger KD
    Pharmacology; 1981; 23(3):149-55. PubMed ID: 6974360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients.
    Edwin D; Flynn L; Klein A; Thuluvath PJ
    Hepatology; 1999 Dec; 30(6):1363-7. PubMed ID: 10573512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug metabolism in alcoholic liver disease.
    Horváth T; Pár A; Past T; Tapsonyi Z; Ruzsa C; Kádas I; Jávor T
    Acta Med Acad Sci Hung; 1982; 39(3-4):169-77. PubMed ID: 7185242
    [No Abstract]   [Full Text] [Related]  

  • 29. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
    Lindskov J
    Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Animal experimental and human pharmacologic studies with phase-II metabolites of triamterene].
    Völger KD
    Arzneimittelforschung; 1991 May; 41(5):499-506. PubMed ID: 1898420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolism of riboflavin in female patients with liver cirrhosis.
    Zempleni J; Galloway JR; McCormick DB
    Int J Vitam Nutr Res; 1996; 66(3):237-43. PubMed ID: 8899458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remethylation and transsulfuration of methionine in cirrhosis: studies with L-[H3-methyl-1-C]methionine.
    Russmann S; Junker E; Lauterburg BH
    Hepatology; 2002 Nov; 36(5):1190-6. PubMed ID: 12395329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
    Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
    Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Age dependence of the pharmacokinetics of triamterene].
    Stopp M; Bräunlich H
    Acta Biol Med Ger; 1973; 30(1):121-32. PubMed ID: 4707945
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Brockmöller J; Thomsen T; Wittstock M; Coupez R; Lochs H; Roots I
    Clin Pharmacol Ther; 2005 Jun; 77(6):529-41. PubMed ID: 15961984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate-induced thermogenesis in liver cirrhosis: glucose vs. fructose.
    Martines D; Martines V; Pasini M; Cocco G; Lora L; Varnier M; Venier GB; Sammartano G; Naccarato R
    Nutrition; 1994; 10(6):521-6. PubMed ID: 7703598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
    Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B
    Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability and elimination kinetics of the combination furosemide-retard/triamterene.
    Schuster O; Loew D; Knoell HE
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):127-32. PubMed ID: 4043142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis.
    Spahr L; Negro F; Leandro G; Marinescu O; Goodman KJ; Rubbia-Brandt L; Jordan M; Hadengue A
    Med Sci Monit; 2003 Jan; 9(1):CR6-11. PubMed ID: 12552242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On the bioavailability of hydrochlorothiazide and triamterene from commercial drugs (author's transl)].
    Knauf H; Möhrke W; Mutschler E; Völger KD
    Arzneimittelforschung; 1980; 30(6):1001-4. PubMed ID: 7191258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.